• leader board size
Case Studies2020-11-19T22:10:23-08:00

Case Studies

What Does Cannabis 3.0 Actually Mean?

LOS ANGELES- If Cannabis 1.0 was legalization and survival, and Cannabis 2.0 was scale and brand proliferation, Cannabis 3.0 is something far more structural. It is the shift from product velocity to process discipline. From ...

Organigram Strikes Deal to Acquire Sanity Group

TORONTO-BERLIN – Organigram Global Inc. has signed a definitive agreement to purchase the remaining shares of Berlin-based Sanity Group GmbH that it does not already hold. The transaction builds on Organigram's earlier minority stake and ...

Atai Gains Nasdaq Biotechnology Index Spot

NEW YORK – AtaiBeckley N.V., the clinical-stage biopharmaceutical firm born from the November merger of atai Life Sciences and Beckley Psytech, has secured a place in the Nasdaq Biotechnology Index (NBI), a move that underscores ...

What Does Cannabis 3.0 Actually Mean?

LOS ANGELES- If Cannabis 1.0 was legalization and survival, and Cannabis 2.0 was scale and brand proliferation, Cannabis 3.0 is something far more structural. It is the shift from product velocity to process discipline. From ...

Organigram Strikes Deal to Acquire Sanity Group

TORONTO-BERLIN – Organigram Global Inc. has signed a definitive agreement to purchase the remaining shares of Berlin-based Sanity Group GmbH that it does not already hold. The transaction builds on Organigram's earlier minority stake and ...

U.S. Cannabis Industry: Growth and Puzzles Across States

LOS ANGELES— The cannabis landscape in the U.S. is rapidly shifting, with each state crafting its narrative. From Maryland's remarkable entry to Michigan's booming market, Illinois's unique challenges, and Colorado's stellar tax earnings, the industry's ...

Filament Health Refiles Q2 Financial Results

LOS ANGELES-- Filament Health Corp. has refiled its second-quarter financial results for the period ending June 30, 2023, following an initial filing on May 12, 2023. The revision was necessitated by changes in the accounting ...

COMPASS Pathways Q2 2023 Financial Analysis

LOS ANGELES-- COMPASS Pathways, a biotech firm in the psychedelic medicine sector, has been under the spotlight since its inception. This year, the company's trajectory remains robust, as evidenced by its recent financial report and ...

Hydrofarm Holdings Group Reports Q2 2023 Financial Results

LOS ANGELES— Hydrofarm Holdings Group, Inc.  an independent manufacturer and distributor of hydroponics equipment and supplies for controlled environment agriculture, unveiled its financial results for the second quarter Key Takeaways from Q2 2023: Net Sales: ...

Subscribe To Our Newsletter

Go to Top